FDA Commissioner Scott Gottlieb will step down from his position April 5. Below are four things to know about the departing FDA chief:
1. His time as a physician. Dr. Gottlieb trained at Mount Sinai School of Medicine in New York City. He completed his residency in internal medicine. He practiced medicine as an attending physician at Stamford (Conn.) Hospital, according to the Los Angeles Times.
2. His time as a patient. He is a cancer survivor, successfully winning the fight against Hodgkin's lymphoma. His experience as a cancer patient prompted Dr. Gottlieb to become a cancer policy adviser for the National Coalition for Cancer Survivorship, according to the Los Angeles Times.
3. His time as FDA commissioner. Dr. Gottlieb was sworn in as the 23rd commissioner of the FDA on May 11, 2017. He quickly became known for cracking down on the e-cigarettes industry and trying to get a handle on the opioid crisis.
4. His next steps. Dr. Gottlieb will head back to the American Enterprise Institute to tackle the rising cost of prescription drugs. The 46-year-old plans to spend about a half-dozen days a month as a resident fellow at the conservative think tank. Before becoming FDA commissioner, Dr. Gottlieb wrote op-eds for the institute.